Besides, a recent study reported that downregulation of CLDN7 due to promoter hypermethylation contributed to human ccRCC progression and poor prognosis [51], indicating DNA methylation may also play vital roles in ccRCC. The gene discussed is CLDN7; the disease is nonpapillary renal cell carcinoma.